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Human immunodeficiency virus (HIV) infections have been characterized by both polyclonal B-
cell activation and enhanced responsiveness to B-cell growth factors on one hand and the loss of
specific antibody (Ab) responses and refractoriness to the normal signals for B-cell activation on
the other. Histopathological studies of lymph node from HIV- and simian immunodeficiency
virus (SIV)-infected individuals have indicated initial follicular hyperplasia and the appearance
of large irregular germinal centers that undergo progressive involution concomitant with
follicular dendritic-cell (FDC) disruption. During this process, follicular dendritic-cell -enriched
lymph-node-cell cultures exhibit increased ability to induce cluster formation ("in vitro germinal
centers"), lymphocyte proliferation and antibody production compared to uninfected controls.
This paper discusses how enhanced FDC-B-cell interaction within SIV-infected germinal centers
may result in a reduced ability to select high-affinity B cells and alter the dynamics of antibody-
producing-cell and memory-cell generation resulting in the observed hyperactivity.
INTRODUCTION
In addition to the well-documented changes in the
level and function of T cells, HIV infections also lead
to dramatic qualitative and quantitative changes in the
B cell compartment in terms of both function and the
specificity of the antibody molecules produced.
In vivo abnormalities in B-cell function include
polyclonal B-cell activation, hypergammaglobulinae-
mia, increased levels of autoantibodies, decreased
ability to mount antigen (Ag)-specific responses,
and premature loss of specific anti-HIV antibodies
(Zolla-Pazner, 1984; Mizuma et al., 1988; Amadori
and Chieco-Bianchi, 1990; Fenouillet et al., 1992).
Accordingly, cultured peripheral blood mononuclear
cells (PBMC) from seropositive patients secrete
antibodies to HIV- and non-HIV-related antigens,
spontaneously or following culture with HIV, and
interleukins (IL), and exhibit decreased responsive-
ness to mitogens (Amadori et al., 1989; Edelman and
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Zolla-Pazner, 1991; Delfraissy et al., 1992; Shirai et
al., 1992). Although the observed polyclonal B-cell
activation occurs early and persists throughout infec-
tion, it is thought to be independent of the specific
humoral anti-HIV response, which clearly predom-
inates during asymptomatic infection, as evidenced by
large number of B cells spontaneously secreting anti-
HIV antibodies in patient blood (Amadori et al., 1989;
Shirai et al., 1992), bone marrow (BM) (Cosentino et
al., 1994), and duodenum (Eriksson et al., 1995). In
addition, antibody-secreting cells (ASC) specific for
HIV proteins and peptides have also been detected
around follicles and in the medulla in HIV+LN
biopsies (Laman et al., 1989). In vitro, the generation
of HIV- and cytokine- (e.g., IL-6, IL-2 plus
interferon-ce [IFN-ce]) induced anti-HIV ASC in
PBMC cultures derived from HIV-seropositive but
not -seronegative individuals further illustrates exten-
sive in vivo activation and expansion of HIV-specific
B cells (Amadori et al., 1991; Delfraissy et al., 1992;
Chirmule et al., 1993).
During the course of disease, which varies amongst
individuals, the number of anti-HIV ASC in blood
and the levels of serum antibody specific for parti-
cular HIV determinants decline. Although the loss of
certain specificities, for example, anti-p24, has been
associated with disease progression, the duration of
specific responses usually has not been shown to
correlate with clinical, immunological, or virologic
parameters (Yarchoan et al., 1986; Shirai et al., 1992;
Binley et al., 1997). In contrast, the increase in
polyclonal B-cell activation has been shown to have
statistical significance among patients with advanced
disease. Thus, in studies using PBMC by Shirai et al.
(1992), high HIV envelope gpl60- and gag p24-
specific B-cell activation decreased, whereas poly-
clonal B-cell activation, as measured by the appear-
ance of B-cell secreting anti-TNP and anti-DNA IgG
antibodies increased during late-stage disease (CDC
class IV). Likewise, the in vitro generation of HIV-
ASC from PBMC from late-stage patients was also
greatly reduced (Delfraissy et al., 1992). How this
transition relates to the process by which ASC are
generated and selected from B-cell precursors in
lymphoid organs and how this loss in ASC reflects
similar changes in tissues are critical to our under-
standing of AIDS pathogenesis.
In this context, histopathological studies on HIV/
SIV organs have revealed dramatic changes in the
follicles (B-cell area) of lymphoid organs that repre-
sent a dynamic process progressing from follicular
hyperplasia to follicular involution (Biberfeld et al.,
1986; Racz et al., 1986; Vago et al., 1989; Persidsky
et al., 1995). During this time, follicular dendritic
cells (FDC), which normally create the environment
in germinal centers (GC) for B cell somatic mutation,
affinity maturation, and isotype switch following
exposure to antigen (Kraal et al., 1982; Jacob et al.,
1991; Liu et al., 1992; Apel and Berek, 1996; Liu and
Banchereau, 1996), also themselves undergo initial
hypertrophy and subsequent fragmentation of their
reticular networks. Although these alterations are not
specific for HIV/SIV infections (Janossy et al., 1991;
Rideout et al., 1992), they are highly characteristic of
HIV/SIV-related lymphadenopathy and are closely
associated with both increased trapping of viral
antigens by FDC and infiltration into the GC of
CD45RAlo CD8 cells known to produce potentially
lytic molecules. (Tenner-Racz et al., 1987; Vago et
al., 1989; Devergne et al., 1991; Tenner-Racz et al.,
1993; Rosenberg et al., 1994b). Since FDC are critical
to the induction of specific ASC precursors and the
generation and maintenance of B-cell memory (Klaus
et al., 1980; MacLennan and Gray, 1986; Tew et al.,
1992), the simplest assumption is that the B-cell
abnormalities observed during infection directly
result from virus-induced changes in the GC environ-
ment. For practical reasons, such studies cannot be
easily performed in humans and our laboratory has
therefore focused on examining the ability of mesen-
teric LN FDC derived from SIV-infected macaques to
support GC formation, lymphocyte growth, and
antibody formation in vitro. The findings demon-
strated that such FDC have enhanced function when
compared to FDC from control cultures. The purpose
of this paper is to describe the possible mechanisms
underlying the decline in certain specific anti-HIV/
SIV titers and polyclonal expansion of B cells
secreting non-HIV-related antibodies in the context of
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RESULTS AND DISCUSSION
The ability of FDC derived from SIV-infected LN to
induce cluster formation, activate and induce pro-
liferation of B and CD8 cells, and to induce Ig and
Ab production has been examined (Rosenberg et al.,
1997). To this end, FDC-enriched mesenteric LN cell
cultures from SIV-infected macaques were func-
tionally compared to two controls: (1) FDC-enriched
mesenteric LN cultures from uninfected macaques
and (2) non-FDC-containing LN-cell suspensions
derived from the same LN. The findings indicated:
1. Greatly enhanced spontaneous cluster formation
in FDC-enriched LN cultures from SIV-infected
macaques. In the absence of exogenous cytokines,
such cultures contained many large clusters compris-
ing thousands of cells in addition to smaller clusters
of 10-100 cells containing predominantly B cells. By
contrast, uninfected monkey donors contained mostly
small clusters, although occasional large clusters were
also observed in uninfected macaques, suggesting
ongoing environmental stimulation leading to GC
formation in vivo. The increased size of the clusters
also corresponded with prolonged cell survival. For
example, FDC-enriched cultures derived from the LN
of the SIV-251-infected macaque 93 days post
infections (pi) supported >40% B cells for 10 days
compared to death of control cultures by 5-7 days. In
the presence of IL-2, CD8 and CD56 cells were also
increased.
2. Enhanced ability of FDC-enriched cultures from
LN of chronically SIV-infected to induce lymphocyte
proliferation. Theses studies indicated that at peak
time points (usually days 2-3), FDC-enriched LN
cultures from infected macaques consistently incor-
porated 3-10 times higher cpm than control non-FDC-
containing cell suspensions prepared from the same
LN or control FDC-enriched cells from LN of
uninfected monkeys. The level of incorporation also
appeared to be associated with the CD4/CD8 ratio of
the LN and the degree to which GC were infiltrated
with CD8 lymphocytes. It should be noted that
the addition of SIV-251 to fresh LN cells in vitro did
not result in cluster formation or proliferation and
may actually suppress anti-CD3-induced proliferation
(unpublished observations).
3. Exogenous IL-2 at the initiation of culture
resulted in greatly elevated lymphocyte proliferation
at D4 in the FDC-enriched population from SIV-
positive LN. For example, the [3H-TdR] incorporation
in FDC-enriched cultures was five fold higher than
that in control non-FDC-containing suspension cul-
tures.
4. High background proliferation in the non-FDC-
containing cell cultures, occasionally observed in
tissues of SIV-infected macaques is rapidly lost in the
absence of FDC and IL-2.
5. Increased production of IgG1 immunoglobulin
and anti-SIV Ab by FDC-enriched cultures from SIV-
infected LN. ELISA results indicate that, in addition
to their requirement for B-cell growth, FDC play an
important role in the high-level production of IgG1
and specific anti-SIV Ab by B cells from infected LN.
No anti-SIV Ab was observed in either of two FDC-
enriched LN preparations derived from uninfected
monkeys. The high levels of Ab specific for SIV do
indicate the commitment of GC in SIV-infected
macaques toward the production of anti-SIV Ab.
6. FDC-dependent clusters predominantly con-
tained activated CD45RAlo CD8 cells and CD56
cells. Unlike clusters from immunized mice or
uninfected human tonsil (Koopman et al., 1991;
Petrasch et al., 1991; Kosco et al., 1992) where CD8
cells are rarely found, FDC-enriched cultures from
infected macaques maintained 10-20% CD8 cells
that were predominantly CD45RAlo. In keeping with
this activated phenotype, the addition of IL-2 to
cultures at day 12 appeared to further select for the
expansion of CD8 cells. In control cultures, CD8
cells were almost totally CD456RAhi.
GC Formation and HIV/SIV Infections
High-affinity IgG and IgA antibody synthesis and the
generation of memory B cells involves complex
cellular interactions among FDC, B cells, and T cells
at several levels (Klaus et al., 1980; MacLennan and
Gray, 1986; Tew et al., 1992). FDC, which initially
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cells in association with the adhesion molecular pairs
lymphocyte function-associated antigen- 1 (LFA- 1)
intercellular adhesion molecule- (ICAM- 1) and very
late antigen-4 (VLA-4) vascular adhesion mole-
cule- 1 (VLA- 1) (Koopman et al., 1991; Kosco et al.,
1992). They also play a subsequent role in selecting
the high-affinity mutants from among the pool of
rapidly dividing centrocytes. Each of these FDC-B-
cell interactions involves the delivery of a costimula-
tory signal(s) from the FDC to the B cell in addition
to the antigen-specific interaction (Burton et al., 1993;
Kosco-Vilbois et al., 1993). Although not yet identi-
fied, possible candidates for the costimulatory signals
include the ligand for CD19, complement fragments
on the FDC surface, other interactions involving
CD23, adhesion molecules or chemokines. The
CD40 B7 high B cells thus selected then present
processed antigen to GC T cells inducing CD40
ligand (CD401) expression and the synthesis of
cytokines such as IL-4 and IL-10, required for further
B-cell proliferation, isotype switching, and Ab secre-
tion. Normally, any B cell that expresses low-affinity
Ig receptors or receptors specific for autoantigens do
not normally receive the appropriate signals for
further maturation, undergo programmed cell death
(PCD) (Liu et al., 1991), and are taken up by tingible
body macrophages.
Following HIV/SIV infections, virus-induced changes
occur in LN GC that may enhance normal FDC-B cell
interactions leading to polyclonal B cell activations and
relative decreases in humoral HIV/SIV specific
responses. During the period of follicular hyperplasia,
GC increase in size and become irregular in shape and
exhibit increased expression of adhesion molecules. The
expanded area within the dark zone shows greatly
increased FDC expression of CD23, rapidly proliferating
KI-67 centroblasts, and an accumulation of infiltrating
CD45RO CD8 cells. In addition the expansion of the
fight zone, where complexed viral antigens are deposited
and CD4 T cells are found, results in a much reduced
mantle zone (Janossy et al., 1991; Joling et al., 1992;
Persidsky et al., 1995). It is not currently known how an
increase in the volume of the reticular network and
increased FDC function relates to quantitative increases
in FDC number. FDC-dependent and T cell-dependent
mechanisms that may account for this observed GC B-
cell hyperactivity consistent with these immunohisto-
logical changes are described below and depicted in
Figure 1.
Increased Survival of Low-Affinity and
Autoreactive B Cells
(i) gpl20 Cross-Linking of Ig Receptors on Low-
Affinity B Cells
As HIV/SIV infections progress, virus particles
become bound to FDC complement receptors (CR)
either directly via C3b, iC3b, and C3d on the virus
(Marschang et al., 1993; Thielens et al., 1993) or via
antibody bridges. Studies in mice with the MAIDS
virus (Masuda et al., 1995) indicate that during the
infection, previously bound soluble nonviral antigens
are also displaced, presumably because virions bear-
ing C3 components dislodge and replace the preexist-
ing Ag-Ab complexes from the complement receptors
on FDC (CR1, CD2, and CR3). In this situation,
presentation of FDC-bound virions expressing mem-
brane gp120 molecules in a spacially ordered arrange-
ment could induce sufficient cross-linking of B-cell Ig
receptors to activate B cells. The increased avidity
resulting from high levels of multipoint binding may
thus overcome affinity considerations and result in the
activation of ceils with very low specificity for viral
antigens, including some high-frequency autoreactive
B cells. Such binding by B cells in the presence of
costimulation signals from FDC might serve to
prevent the downregulation of Bcl-2 and up regula-
tion of CD95 as) (Garrone et al., 1995) expression
and render the cells susceptible to T-cell-derived
signals, rescuing them from PCD that would normally
have been their fate. Several predictions can be made
according to this scenario: (1) Initially, depending on
the B-cell repertoire of the individual, less stringent
selection might result in an overall decrease in the
percentage of total effective anti-HIV ASC, whereas
that for other B-cell specificities might increase; and
(2) whereas anti-gpl20 antibody responses would be
maintained at relatively high levels, those specific for
monomeric soluble proteins, would remain low or be
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(Binley et al., 1997); and (3) in studies using duodenal
biopsies from AIDS patients, a marked decrease in the
numbers of ASC specific for the soluble antigens
keyhole limpet hemocyanin and dog serum albumin
in the absence of any decline in the percent anti-
gp160 ASC (Eriksson et al., 1995).
(ii) Increased Expression of Adhesion and
Activation Molecules on B Cells and FDC
Cytokines play a critical role in mediating immune
function; the pattern of cytokine production determin-
ing the type of immune response generated. In
addition, cytokines such as IFN-y and turnout
necrosis factor-c (TNF-c0 are known to induce
chemokines (Ebnet et al., 1996) and regulate lympho-
cyte migration and sequestration by virtue of their
ability to induce adhesion molecules, eg, ICAM-1,
VCAM-1, LFA-1 on lymphocytes, antigen-presenting
cells, and vascular endothelium (Anderson and Rey-
nolds, 1979; Mackay, 1991; Colditz and Watson,
1992; May and Ager, 1992; Adams et al., 1994).
Since the ability of FDC-enriched LN cells to form
clusters in vitro is known to be dependent on LFA-
1-ICAM- 1 and VLA-4-VCAM- 1 interactions (Koop-
man et al., 1991; Kosco et al., 1992), it is highly likely
that CD8 cell-derived IFN-y production in GC
(Emilie et al., 1990; Graziosi et al., 1994) (unpub-
lished observation) can induce increased expression
of ICAM-1 and VCAM-1 on FDC and facilitate their
binding to B cells. Enhanced VCAM-1 expression has
been demonstrated in reactive human LN (Ruco et al.,
1992) and more recently on FDC in GC of SIV-
infected LN (Persidsky et al., 1995). Although
increases in cells producing IL-1, IL-4, IL-6, TNF-c,
and IFN-y have been reported in LN and blood from
HIV and SIV-infected individuals (Emilie et al.,
1990; Fan et al., 1993; Graziosi et al., 1994;
Rosenberg et al., 1994a; Persidsky et al., 1995), a
comparison with the appropriate control LN or blood
from uninfected monkeys or from humans with HIV-
unrelated hyperplasia has indicated to date that only
IFN-y production is consistently increased throughout
infection.
Another alteration observed in GC of HIV-infected
LN is the greatly increased expression of CD23
antigen in the expanded part of the "dark" zone:
CD23 being expressed normally only on FDC and B
cells in the apical light zone. This CD23 positivity,
which may result from IL-4 synthesis or increased
numbers of immune complexes or FDC (Maeda et al.,
1992) may increase signalling to B cells via inter-
action with CD21 (Bonnefoy et al., 1993) and may
skew the maturation ofB cells into plasma cells rather
than memory cells (Liu and Banchereau, 1996).
Regardless of whether binding of integrins with their
ligands or CD23 with CD21 is able to generate
maturation signals in vivo (Liu et al., 1992; Bonnefoy
et al., 1993; Adams et al., 1994; Lub et al., 1995; Liu
and Banchereau, 1996), it is possible that such
interactions may augment low-affinity binding of
FDC-bound antigen to membrane Ig sufficient to
allow the costimulation and/or differentiation of low-
affinity B cells that would normally have been
destined to die.
Increase in T-Cell-Derived Maturation and
Differentiation Signals
Maturation and differentiation of activated B cells
into IgG and IgA ASC or memory cells require the
participation of T cells either via cognate CD40-
CD40L or B7-CD28 interactions and the elaboration
of cytokines eg. IL-4 and IL-10 (Liu and Banchereau,
1996), or via nonspecific T-cell-derived signals, eg.,
TNF-ce and IL-2 (Macchia et al., 1993). In the former
case, LN GC from HIV+ individuals have been shown
to have increased expression of CD40 ligand
(Janossy, personal communication). In addition,
although different studies have published variable
findings with respect to IL-10 secretion/expression
(Montaner, 1994), the evidence to date shows no
obvious reduction in IL-10 levels in LN or blood
during HIV infection. The high levels of IgG
produced during HIV/SIV infections indicate that
sufficient T-cell help is present to induce isotype
switching.
In the case of nonspecific signaling, TNF-ce,
produced by CD4 cells from HIV patients or infectedFDC FUNCTION AND HIV/SIV INFECTIONS 67
cells in vitro, is able to induce IgG production by
syngeneic (presumably activated) B cells (Macchia et
al., 1993). In this way, any B cell of varying affinity
for HIV antigens that are rescued by interaction with
HIV-coated FDC and express TNF receptors or 2
(TNFR-1 or 2) may be induced to secrete Ig. The
TNF-c and IL-6 families of molecules are important
at several levels. Thus, in addition to the critical role
of TNF-c, lymphotoxin-a (LT-c0, and TNFR-1 on
FDC generation, GC formation and the levels of IgG
production as recently demonstrated using knockout
mice (Le Hir et al., 1996; Matsumoto et al., 1996), IL-
6 is produced by FDC (M. K.-V., unpublished
observation) and is important in spontaneous anti-
HIV production by B cells (Amadori et al., 1991;
Delfraissy et al., 1992). Furthermore TNF-c and IL-6
cytokines have also been closely linked with
increased HIV and SIV replication (Birx et al., 1993;
Scala et al., 1994; Virelizier, 1994), thereby increas-
ing antigen levels.
Finally, it is noteworthy that whereas B cells
constitute roughly 30% of total lymphocytes in the
body, usually only 10-20% of the 1-2% of lymphocytes
that circulate in the blood at any time are B cells
(Westermann and Pabst, 1992). Thus the usual sampling
of PBMC may not be an accurate means of assessing
overall B-cell function. Accordingly, (1) the number of
peripheral blood B cells secreting anti-gp-160 antibody
shows no significant correlation with serum anti-HIV
gp-160 antibody concentrations (Schwartz et al., 1994);
(2) BM contains >30-fold more anti-gpl60 ASC than
blood following immunization with gp160 (Cosentino et
al., 1994); and (3) levels of HIV-specific ASC in
duodenal biopsies and BM are present in large numbers
throughout infection when numbers in blood are very
low (Eriksson et al., 1995). These results emphasize the
need to examine tissues and not just blood in order to
elucidate the mechanisms underlying the observed
hyperactivity. In this context, another caveat arises
because during the budding process, HIV virions
become enveloped by the lipid bilayer of the host cell
and simultaneously by many host-cell proteins (Arthur
et al., 1992; Meerloo et al., 1993; Dierich, unpublished
observation). The extent to which such molecules may
be responsible for the increased expression of adhesion
and activation molecules and receptors as well as
enhanced effector function observed in HIV+ GC are
currently only beginning to be understood.
MATERIALS AND METHODS
Animals and Infections
Rhesus macaques were infected with 1-10 tissue
culture infectious doses 50 (TCIDso) of SIV-251 and
sacrificed between days 93 and 535, at which time
mesenteric LN were removed for assaying. Control
LN were collected from rhesus and pig-tailed
macaques (Regional Primate Center, Seattle, WA).
Analysis of Lymphocyte Populations by Flow
Cytometry (FCM)
Fresh or cultured cells were double or triple stained with
fluorescein isothyiocyanate (FITC)-coupled CD45RA
mAb (Gentrak, Wayne, PA), anti-CD4, and CD56
coupled to phycoerythrin (PE) and CD20 and CD8
mAbs coupled to either FITC or peridinin chlorophyll
protein (PerCP; Becton Dickenson, Mountain View,
CA). Analysis was done on a FACScan (Becton
Dickenson).
Isolation of Cells and Culture Conditions
FDC-enriched cultures were prepared using mesen-
teric LN from uninfected or SIV-infected macaques
according to the method of Schnizlein et al. (1985)
with modifications (Kosco et al., 1992; Rosenberg et
al. 1997). Cultured cells were analyzed phenotyp-
ically by FCM and for their proliferative ability by the
incorporation of [3H]-TdR following a 6-8-hr pulse.
In some cases, 1-ml cultures (2.5 106 cells/well)
were set up and 100-/xl aliquots from each of three
wells were pulsed with [3H]-TdR before harvesting
producing similar results. Other control cultures were
comprised of single-cell suspensions produced by
passing a portion of the same unfractionated LN
through a sieve; such mechanical disruption results in
the destruction of the FDC (Schnizlein et al., 1985).
Although the latter controls may be suboptimal due to68 Y.J. ROSENBERG et al.
a loss of plasma cells and blasts noted using this
method, the rapid loss of LN cells with high-
background incorporation in some of these FDC-
deprived cultures served to indicate the important role
of FDC in sustaining proliferation.
Immunoglobulin and Anti-SIV Antibody Assays
IgG1 levels and anti-SIV antibody levels were
measured using commercial ELISA kits, which cross
react with macaque immunoglobulin obtained from
The Binding Site (Birmingham, UK) and Genetic
Systems (Seattle, WA).
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